Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future
yahoo.com
news
2022-06-02 03:00:00

NANJING, China, June 1, 2022 /PRNewswire/ -- Vazyme, China's leading biotechnology company, has recently released its 2021 annual report, revealing that the company has maintained a steady and solid growth throughout the past year. The report shows that it has achieved $289 million in operating income with an increase of 19.44% year-on-year. The company's R&D investment reached $36 million, up 83.47%, representing 12.33% of its total operating income.

"The year 2022 is still full of opportunities and challenges.
